Gestational Diabetes Mellitus in Early Pregnancy: Evidence for Poor Pregnancy Outcomes Despite Treatment
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Recent guidelines recommend testing at <24 weeks of gestation for maternal dysglycemia in “high-risk” women. Evidence to support the early identification and treatment of gestational diabetes mellitus (GDM) is, however, limited. We examined the prevalence, clinical characteristics, and pregnancy outcomes of high-risk women with GDM diagnosed at <24 weeks of gestation (early GDM) and those with pre-existing diabetes compared with GDM diagnosed at ≥24 weeks of gestation, in a large treated multiethnic cohort. RESEARCH DESIGN AND METHODS: Outcomes from 4,873 women attending a university hospital antenatal diabetes clinic between 1991 and 2011 were examined. All were treated to standardized glycemic targets. Women were stratified as pre-existing diabetes (n = 65) or GDM diagnosed at <12 weeks of gestation (n = 68), at 12–23 weeks of gestation (n = 1,247), or at ≥24 weeks of gestation (n = 3,493). RESULTS: Hypertensive disorders in pregnancy including pre-eclampsia, preterm delivery, cesarean section, and neonatal jaundice (all P < 0.001) were more prevalent in women with pre-existing diabetes and early GDM. Macrosomia (21.8% vs. 20.3%, P = 0.8), large for gestational age (39.6% vs. 32.8%, P = 0.4), and neonatal intensive care admission (38.5% vs. 39.7%, P = 0.9) in women in whom GDM was diagnosed at <12 weeks of gestation were comparable to rates seen in women with pre-existing diabetes. CONCLUSIONS: Despite early testing and current best practice treatment, early GDM in high-risk women remains associated with poorer pregnancy outcomes. Outcomes for those in whom GDM was diagnosed at <12 weeks of gestation approximated those seen in pre-existing diabetes. These findings indicate the need for further studies to establish the efficacy of alternative management approaches to improve outcomes in these high-risk pregnancies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, outcomes for women with GDM diagnosed before 12 weeks of gestation are similar to those in women with preexisting diabetes (281).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [281]
In the citing paper
“There is evidence that women diagnosed with GDM early in pregnancy are more likely to have adverse outcomes.”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [281]
Citations
Cites
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390
Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
A Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes
Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. W., Ramin, S. M., Casey, B., Wapner, R. J., Varner, M. W., Rouse, D. J., Thorp, J. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902430 · Cited by 2,122 · cited 1×
“The seminal Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study (1) unequivocally demonstrated a continuouspositive relationshipbetweenmaternal blood glucose levels (BGLs) and several adverse maternal and neonatal outcomes, while intervention studies (7,8) have shown that treatment of GDM after 24 weeks of gestat…”
BackgroundMetzger, B. E., Gabbe, S. G., Persson, B., Lowe, L. P., Dyer, A. R., Oats, J. J. N., & Buchanan, T. A. (2010) · Diabetes Care · doi:10.2337/dc10-0719 · Cited by 1,888
Maternal Obesity and Risk of Gestational Diabetes Mellitus
Chu, S. Y., Callaghan, W. M., Kim, S. Y., Schmid, C. H., Lau, J., England, L. J., & Dietz, P. M. (2007) · Diabetes Care · doi:10.2337/dc06-2559a · Cited by 1,114
The Hyperglycemia and Adverse Pregnancy Outcome Study
Catalano, P. M., McIntyre, H. D., Cruickshank, J. K., McCance, D. R., Dyer, A. R., Metzger, B. E., Lowe, L. P., Trimble, E. R., Coustan, D. R., Hadden, D. R., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1790 · Cited by 954
(2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.10.012 · Cited by 914
Torloni, M. R., Betrán, A. P., Horta, B. L., Nakamura, M. U., Atallah, A. N., Moron, A. F., & Valente, O. (2009) · Obesity Reviews · doi:10.1111/j.1467-789x.2008.00541.x · Cited by 739
Macintosh, M. C. M., Fleming, K. M., Bailey, J. A., Doyle, P., Modder, J., Acolet, D., Golightly, S., & Miller, A. (2006) · BMJ · doi:10.1136/bmj.38856.692986.ae · Cited by 673
Research works printed but not linked: 1
- Barker, 1994, Mothers, Babies and Diseases in Later Life
Cited by
Items 101–200 of 265
Kasuga, Y., Kawai, T., Miyakoshi, K., Hori, A., Tamagawa, M., Hasegawa, K., Ikenoue, S., Ochiai, D., Saisho, Y., Hida, M., et al. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002539 · Cited by 14
Extracellular Vesicles—New Players in Cell-to-Cell Communication in Gestational Diabetes Mellitus
Palma, C., McIntyre, D. H., & Salomón, C. (2022) · Biomedicines · doi:10.3390/biomedicines10020462 · Cited by 15
“Previously, it was shown in Australia that macrosomia, LGA and neonatal intensive care admission cases were comparable between GDM patients and pre-existing diabetes patients, even if the diagnosis of GDM was before 12 weeks of gestation [23].”
ResultHeyborne, K., & Barbour, L. A. (2024) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000005777 · Cited by 14
Huhn, E. A., Göbl, C. S., Fischer, T., Bernasconi, M. T., Kreft, M., Kunze, M., Vogt, D., Dölzlmüller, E., Jaksch‐Bogensperger, H., Heldstab, S. A., et al. (2022) · BMJ Medicine · doi:10.1136/bmjmed-2022-000330 · Cited by 15
Undernutrition during Pregnancy
Nguyen, H. A. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.82727 · Cited by 18
“Several adverse outcomes are associated with diabetes during a pregnancy: mothers with the untreated GDM have a higher risk of hypertension, preeclampsia, cesarean delivery, and labor complications; their babies are at increased risk of macrosomia, large for gestational age, fetal organomegaly, shoulder dystocia, hypo…”
BackgroundRamadan and gestational diabetes: maternal and neonatal outcomes
AlMogbel, T. A., Ross, G. P., Wu, T., Molyneaux, L. M., Constantino, M. I., McGill, M. J., Harding, A. J., Pech, C., Alrasheed, A. A., & Wong, J. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01782-y · Cited by 15
Self-citationPunnose, J., Malhotra, R. K., Sukhija, K., Rijhwani, R. M., Choudhary, N., Sharma, A., Vij, P., & Bahl, P. (2022) · Diabetic Medicine · doi:10.1111/dme.14993 · Cited by 16
Importance of early elevated maternal HbA1c levels in identifying adverse fetal and neonatal events
Yu, H., Wang, J., Shrestha, Y., Hu, Y., Ma, Y., Ren, L., Zhang, J., & Li, J. (2019) · Placenta · doi:10.1016/j.placenta.2019.07.008 · Cited by 16
Rate of Spontaneous Preterm Delivery Between Pregnant Women With and Without Gestational Diabetes
Tanpong, S., & Boriboonhirunsarn, D. (2023) · Cureus · doi:10.7759/cureus.34565 · Cited by 26
“Some previous studies also reported increased risk of preterm delivery as well as other adverse outcomes among GDM women that were detected early in pregnancy despite treatment [14,15].”
BackgroundDeng, Y., Jin, H., Ning, J., Cui, D., Zhang, M., & Yang, H. (2023) · Molecular Medicine · doi:10.1186/s10020-023-00707-5 · Cited by 14
“Previous studies (Sweeting et al. 2016; Geurtsen et al. 2019) had shown that hyperglycemia in early pregnancy was associated with adverse pregnancy outcomes, these findings provided some insights into earlier interventions of GDM.”
ResultCurrent approach to early gestational diabetes mellitus: A clinical update
Goyal, A., & Gupta, Y. (2025) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2025.103256 · Cited by 13
Stillbirth in women with diabetes: a retrospective analysis of fetal autopsy reports
Lynch, T. A., Westen, E. A., Li, D., Katzman, P. J., Malshe, A. K., & Drennan, K. J. (2020) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2020.1779213 · Cited by 11
“[15] As we were unable to determine the exact timing of diagnosis for all patients with documented gestational diabetes A2, we chose to group these pregnancies together.”
Predictors of later insulin therapy for gestational diabetes diagnosed in early pregnancy
Tamagawa, M., Kasuga, Y., Saisho, Y., Tanaka, Y., Hasegawa, K., Oishi, M., Endo, T., Sato, Y., Ikenoue, S., Tanaka, M., et al. (2021) · Endocrine Journal · doi:10.1507/endocrj.ej21-0118 · Cited by 14
“Women with EGDM have a higher frequency of preterm births than women with L-GDM, in addition to increased HDP, preeclampsia, CS, admission to neonatal intensive care units, macrosomia delivery, and babies who are LGA with neonatal jaundice [5-8].”
BackgroundMaternal and neonatal outcomes following a diabetic pregnancy within the context of HIV
Soepnel, L. M., Nicolaou, V., Huddle, K., Klipstein‐Grobusch, K., Levitt, N. S., & Norris, S. A. (2019) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12956 · Cited by 17
Intermediate hyperglycemia in early pregnancy: A South Asian perspective
Punnose, J., Sukhija, K., & Rijhwani, R. M. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i5.573 · Cited by 14
Tano, S., Kotani, T., Ushida, T., Yoshihara, M., Imai, K., Nakamura, N., Iitani, Y., Moriyama, Y., Emoto, R., Kato, S., et al. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01103-z · Cited by 11
“However, GDM diagnosed in early pregnancy has comparable risks to pre-existing DM [29].”
BackgroundYokoyama, M., Miyakoshi, K., Iwama, N., Yamashita, H., Yasuhi, I., Kawasaki, M., Arata, N., SATO, S. T., Imura, Y., Waguri, M., et al. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14368 · Cited by 12
“Several investigations have revealed that postpartum glucose intolerance is more LGDM, diagnosed after 24 weeks pregnancy; OGTT, oral glucose tolerance test. frequent in early GDM than in late GDM 8,15,21,22 .”
InfluentialRedman, L. M., Drews, K. L., Klein, S., Horn, L. V., Wing, R. R., Pi-Sunyer, X., Evans, M. E., JOSHIPURA, K. J., Arteaga, S. S., Cahill, A. G., et al. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108549 · Cited by 13
Kulkarni, J., Gurvich, C., Gilbert, H., Worsley, R., Li, Q., & Karimi, L. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.01.030 · Cited by 12
li, J., Liu, X., He, S., & Ren, Y. (2025) · JMIR Medical Informatics · doi:10.2196/71539 · Cited by 14
“…found that women diagnosed with GDM before 12 weeks of pregnancy had worse pregnancy outcomes compared to those diagnosed between 24 ‐ 28 weeks [23]; the research by Mustafa et al [7] also found that women with early onset (<24 weeks) GDM had higher BMI, significantly increased demand for…”
Fasting glucose in the first trimester: An initial approach to diagnosis of gestational diabetes
del Val, T. L., Lázaro, V. A., Lacalle, C. G., Moreno, B. T., Carbajal, G. C., & Fernandez, B. A. (2019) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2019.01.001 · Cited by 12
Cosma, V., Imbernon, J., Zagdoun, L., Boulot, P., Renard, É., Brunet, C., Marès, P., Rodier, M., Kabani, S., Dematteï, C., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-89679-2 · Cited by 11
Gao, R. C., Zhao, K., Zhou, J., Wang, X., Liu, T., Lian, S., Li, J., Huang, Y., Qiu, C., Wu, Y., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.977195 · Cited by 12
Zaccara, T. A., Paganoti, C. D. F., Mikami, F. C. F., Francisco, R. P. V., & da Costa, R. A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192113719 · Cited by 13
“It is essential to highlight that both Bozkurt’s and Sweeting’s studies considered the diagnosis of GDM for women with abnormal results from an early OGTT, not just FPG.”
BackgroundResultInfluentialDoes Dietitian Involvement During Pregnancy Improve Birth Outcomes? A Systematic Review
Hanifi, M., Liu, W., Twynstra, J., & Seabrook, J. A. (2023) · Canadian Journal of Dietetic Practice and Research · doi:10.3148/cjdpr-2023-014 · Cited by 10
Neighborhood Deprivation and Racial Disparities in Early Pregnancy Impaired Glucose Tolerance
Dolin, C. D., Mullin, A. M., Ledyard, R. F., Bender, W. R., South, E. C., Durnwald, C. P., & Burris, H. H. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20126175 · Cited by 10
“While early identification of IGT has not been shown to improve maternal and neonatal outcomes, this may be due to early fetal programming and interventions occurring too late in gestation to impact outcomes demonstrating the need to focus on preconception health [7,8].”
BackgroundKapustin, R. V., Kopteeva, E. V., Tiselko, A. V., Alekseenkova, E. N., Валентинович, К. А., Shelaeva, E., Arzhanova, O. N., & Kogan, I. Y. (2023) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-023-07187-2 · Cited by 11
Fazel-Sarjoui, Z., Amirali, K. N., Kamali, M., Namini, N. K., & Tajik, A. (2016) · International Journal of Reproductive BioMedicine (IJRM) · doi:10.29252/ijrm.14.4.275 · Cited by 10
“and metabolic disorders resulting in need to further care leading to higher health care costs (4).”
Backgrounddel Val, T. L., Lázaro, V. A., Lacalle, C. G., Moreno, B. T., Carbajal, G. C., & Fernandez, B. A. (2018) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2018.06.012 · Cited by 13
“Abortos previos, n (%) 351 (28,3) 54 (27,9) 0,5”
Skin Autofluorescence of Pregnant Women With Diabetes Predicts the Macrosomia of Their Children
Foussard, N., Cougnard‐Grégoire, A., Rajaobelina, K., Delcourt, C., Helmer, C., Lamireau, T., Gonzalez, C., Grouthier, V., Haissaguerre, M., Blanco, L., et al. (2019) · Diabetes · doi:10.2337/db18-0906 · Cited by 10
“For GDM, early diagnosis before 12 weeks of gestation (21) and early HbA1c $5.”
Walker, A. R., & Caughey, A. B. (2020) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2020.1716213 · Cited by 11
“It is clear that early treatment does improve outcomes in women with diabetes, and for women at high risk of glucose intolerance, early detection and intervention are key to their prenatal care [8,11].”
BackgroundYuan, K., Wang, H., Chen, Y., Li, S., Wang, Q., Cao, Y.-M., Gao, S., Xu, X., & Xie, Q. (2020) · Annals of Palliative Medicine · doi:10.21037/apm.2020.03.16 · Cited by 11
Investigating the Relationship between Magnesium levels and Diabetes Mellitus in Pregnant Women.
Musavi, H., Tahroodi, F. M., Fesahat, F., Bouzari, Z., Esmaeilzadeh, S., Elmi, F., Yazdani, S., & Moazezi, Z. (2019) · PubMed Central · doi:10.22088/ijmcm.bums.8.3.223 · Cited by 13
Inhibition of fatty acid binding protein 4 attenuates gestational diabetes mellitus
Dong, X., & Yang, L. (2020) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2020.102179 · Cited by 12
Zhao, A., Yang, Y., Yang, Y., Chi, Z., & Sun, Y. (2024) · American Journal of Reproductive Immunology · doi:10.1111/aji.70017 · Cited by 10
“GDM poses significant risks to pregnancy outcomes, including preeclampsia, preterm labor, and miscarriage, thereby increasing neonatal mortality [28].”
Hannah, W., Deepa, M., Ram, U., Versace, V. L., Namara, K. M., Martin, E., Hemavathy, S., Mohaneswari, D., Shivashri, C., Dasari, P., et al. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.113023 · Cited by 12
Agha-Jaffar, R., Oliver, N. S., Kostoula, M., Godsland, I. F., Yu, C.-S., Terry, J., Johnston, D. G., Gable, D. R., & Robinson, S. (2019) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2019.1593959 · Cited by 9
Schiller, T., Barak, O., Shafran, Y. W., Sacagiu, M., Cohen, L., Vaisbuch, E., Zornitzki, T., & Kirzhner, A. (2023) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2023.2191153 · Cited by 11
“suggests that it should be strongly considered [16].”
BackgroundCheung, N. W., Rhou, Y. J. J., Immanuel, J., Hague, W. M., Teede, H. J., Nolan, C. J., Peek, M. J., Flack, J. R., McLean, M. P., Wong, V., et al. (2024) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2024.111929 · Cited by 8
Self-citationWalker, E., Flannery, O., & Mackillop, L. H. (2020) · Primary care diabetes · doi:10.1016/j.pcd.2020.05.010 · Cited by 12
Verbessert ein frühes Screening die perinatalen Ergebnisse?
Sontag, I., & Adamek, H. E. (2024) · Info Diabetologie · doi:10.1007/s15034-024-5054-3 · Cited by 7
“Dieser neigt zu komplikationsträchtigeren Schwangerschaftsverläufen trotz Behandlung, mit erhöhter „large for gestational age“(LGA)-Ra- te [5, 6].”
Screening for gestational diabetes in pregnancy in Northwestern Ontario
Poirier, J., Kattini, R., Kelly, L., Madden, S., Voth, B., Dooley, J., Marazan, B., & Hummelen, R. (2020) · Canadian Journal of Rural Medicine · doi:10.4103/cjrm.cjrm_51_19 · Cited by 7
Munda, A., Šturm, B., Okanovič, G., Zorko, K., Steblovnik, L., & Barlovič, D. P. (2022) · Slovenian Journal of Public Health · doi:10.2478/sjph-2023-0004 · Cited by 8
“(32), which showed that early GDM diagnosis did not substantially improve perinatal outcomes, we assume that worse perinatal outcomes may be prevented at our 10.”
Poupon, P., Foussard, N., Helmer, C., Cougnard‐Grégoire, A., Rajaobelina, K., Delcourt, C., Lamireau, T., Haissaguerre, M., Blanco, L., Lugat, A., et al. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.07.003 · Cited by 9
Sugimoto, M., Sampa, K., Tsukitome, H., Kato, K., Matsubara, H., Asami, S., Sekimoto, K., Kitano, S., Yoshida, S., Takamura, Y., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm11010165 · Cited by 7
“Similar to our result for Cohort 1, the general complications with GDM patients have been reported to be fewer than those of patients with pexD [15].”
ResultYang, X., Zhang, Y., Xu, Y., Xu, Y., Zhang, M., Guan, Q., Hu, W., Tun, H. M., & Xia, Y. (2025) · Environmental Science & Technology · doi:10.1021/acs.est.5c01076 · Cited by 6
Personalizing therapy in early gestational diabetes
Thakkar, S., Saravanan, P., Nagendra, L., & Bhattacharya, S. (2025) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000931 · Cited by 7
Punnose, J. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i10.108254 · Cited by 9
“In a retrospective analysis, Sweeting et al [56] observed that the adverse pregnancy events among women having GDM in the first trimester (after exclusion of preexisting diabetes) were comparable to those observed among pregnant women with preexisting diabetes.”
Iwama, N., Sugiyama, T., Metoki, H., Kusaka, H., Maki, J., Nishigori, H., Yaegashi, N., Sagawa, N., Hiramatsu, Y., & Toyoda, N. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.07.017 · Cited by 6
Neurodevelopment of high and low-risk pregnancy babies at 6 months of age
Romero‐Gonzalez, B., Caparrós-González, R. A., Cruz-Martínez, M., González-Pérez, R., Gallego-Burgos, J. C., & Peralta‐Ramírez, M. I. (2020) · Midwifery · doi:10.1016/j.midw.2020.102791 · Cited by 7
Barbour, L. A., & Davies, J. K. (2017) · Diabetes Care · doi:10.2337/dc17-0554 · Cited by 6
“$24 weeks were more likely to require insulin and neonatal intensive care admission (3).”
BackgroundSagili, H., Priyanka, R., Kuruvilla, A., Duraiswamy, M., Keepanasseril, A., Plakkal, N., Nair, S. N., Mohan, V., & Kamalanathan, S. (2025) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.70568 · Cited by 7
“19,24,35 Currently, there is no consensus on the criteria to be used for the diagnosis of EGDM.”
Ruiz, D., Santibáñez, M., Lavín, B. A., Álvarez, I., Berja, A., Montalbán, C., & Vázquez, L. A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11113003 · Cited by 7
“Despite this recommendation, nearly one-third of GDM diagnoses can occur before the 24th week, and these pregnant women with “early GDM” have an increased risk of complications compared to pregnant women with “late GDM” [5].”
BackgroundSteigt jetzt das Risiko für Geburtskomplikationen?
Sontag, I., & Adamek, H. E. (2023) · Info Diabetologie · doi:10.1007/s15034-023-4499-0 · Cited by 5
Neonatal Outcome in Early and Late Gestational Diabetes Mellitus
Misra, S. C., & Das, N. K. (2017) · Journal of Nepal Paediatric Society · doi:10.3126/jnps.v37i1.16426 · Cited by 5
Zhang, Y., Lu, S., & Li, R. (2016) · Chinese Medical Journal · doi:10.4103/0366-6999.190662 · Cited by 5
Diagnosis of gestational diabetes: Evidence and pitfalls
Wong, T., Immanuel, J., Wong, V. W., Barnes, R., & Simmons, D. (2025) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2025.102069 · Cited by 4
Sontag, I., Kschischo, M., Kaltheuner, M., Jander, L., Leubner, P., Adamczewski, H., Weber, D., Hasenburg, A., Adamek, H. E., GestDiab Group, et al. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-02000-3 · Cited by 4
“…of a previous pregnancy complicated by GDM significantly predisposes women to eGDM [34] They also presented with increased gravidity and parity, in line with previous literature [13] Interest-ingly, a family history of diabetes mellitus revealed only limited predictive features in our study.”
Rao, C., & Ping, F. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1013663 · Cited by 5
Maternal prepregnancy obesity and gestational diabetes influence on adverse perinatal outcomes
de Carvalho, L. S., de Oliveira, A. A. D., Grabovski, T. C. M., Renzo, C. C., Silva, R. R. E., Loz, S. H., & Silva, J. C. (2023) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000605 · Cited by 7
“This allowed the exclusion of patients with overt diabetes, reduced loss of GDM cases in low-risk populations and optimized early GDM detection and management, enhancing the measurement of the impact of treated GDM on pregnancy outcomes (7,12).”
BackgroundDai, Y., Lu, S., & Hu, W. (2024) · Health Science Reports · doi:10.1002/hsr2.70115 · Cited by 5
Hazrat, H., Ahmed, S., & Noushad, S. (2018) · INTERNATIONAL JOURNAL OF ENDORSING HEALTH SCIENCE RESEARCH (IJEHSR) · doi:10.29052/ijehsr.v6.i3.2018.25-33 · Cited by 4
Kuehn, J., Gebuehr, A., Wintour, J., Woods, A., Luu, J. M., & Wynne, K. (2020) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/ajo.13254 · Cited by 4
Can the First Fasting Plasma Glucose Test in Pregnancy Predict Subsequent Gestational Complications?
Burlina, S., Dalfrà, M. G., Belloni, P., Ottanelli, S., Mecacci, F., Mello, G., & Lapolla, A. (2022) · International Journal of Endocrinology · doi:10.1155/2022/9633664 · Cited by 5
“In previous studies, it was only the early diagnosis of GDM - not FFPG—that was found associated with a greater need for insulin treatment during pregnancy [23, 24].”
Nakanishi, S., Aoki, S., Shindo, R., Obata, S., Kasai, J., & Miyagi, E. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01124-1 · Cited by 4
Midwifery awareness of diabetes in pregnancy screening guidelines in Aotearoa New Zealand
Chepulis, L. M., Morison, B. J., Tamatea, J. A. U., Paul, R. G., Wolmarans, L., & Martis, R. (2021) · Midwifery · doi:10.1016/j.midw.2021.103230 · Cited by 5
Wang, N., Han, B. R., Hong, S., Shi, X., Lin, G., Xu, X., Zhou, Y., Wen, X., Sun, B., Wang, H., et al. (2025) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-025-08309-1 · Cited by 3
Gao, B.-B., Zhang, Q., Dong, S.-Q., Gao, F., Liu, X., Wei, J., & Yu, L. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s436178 · Cited by 4
Garvey, Z., Gupta, A., Taylor, N., Thirunavukkarasu, M., & Maulik, N. (2025) · Metabolites · doi:10.3390/metabo15030180 · Cited by 4
“These offspring are also more likely to develop T1DM or T2DM later in life, with offspring born to mothers with GDM more likely to develop impaired glucose tolerance between the ages of 10 and 14 [32].”
Plekhanovа, M. A., Фархадовна, Б. Ф., Petrukhin, V. A., Panov, A. E., Сергеевна, Б. Т., Лысенко, С. Н., Troitskaya, M. V., & Zasypkina, O. S. (2021) · Russian Bulletin of Obstetrician-Gynecologist · doi:10.17116/rosakush20212102144 · Cited by 4
Sfameni, S. F., Wein, P., & Ngu, A. (2021) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.14043 · Cited by 4
Olagbuji, B. N., Aderoba, A. K., Olagbuji, Y., Enikuomehin, A. C., Adewole, A., Awe, C. O., Akadiri, O., & Gestational Diabetes Study Group—Nigeria (2022) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.14102 · Cited by 4
Punnose, J., Malhotra, R. K., Sukhija, K., Rijhwani, R. M., Choudhary, N., & Sharma, A. (2024) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-024-07422-4 · Cited by 3
Kasuga, Y., Takahashi, M., Kajikawa, K., Akita, K., Otani, T., Ikenoue, S., & Tanaka, M. (2024) · Nutrients · doi:10.3390/nu16111553 · Cited by 3
“Furthermore, the incidence of LGA and macrosomia in Early GDM was significantly higher than that in Late GDM [9,10].”
ResultKasuga, Y., Takahashi, M., Kajikawa, K., Akita, K., Tamai, J., Fukuma, Y., Tanaka, Y., Hasegawa, K., Otani, T., Ikenoue, S., et al. (2024) · Journal of Diabetes Investigation · doi:10.1111/jdi.14318 · Cited by 3
Demographics, prevalence and outcomes of diabetes in pregnancy in NW Ontario
Kelly, L., Hummelen, R., Kattini, R., Poirier, J., Madden, S., Ockenden, H., & Dooley, J. (2020) · Canadian Journal of Rural Medicine · doi:10.4103/cjrm.cjrm_71_19 · Cited by 3
Ng, A. Y. T., Liu, A., & Nanan, R. K. H. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.12974 · Cited by 3
Review of Prediabetes and Hypertensive Disorders of Pregnancy
Carris, N. W., Nwabuobi, C. K., He, W., Bullers, K., Wilson, R. E., Louis, J. M., & Magness, R. R. (2019) · American Journal of Perinatology · doi:10.1055/s-0039-1698831 · Cited by 4
Jokelainen, M., Kautiainen, H., Nenonen, A., Stach‐Lempinen, B., & Klemetti, M. M. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01290-3 · Cited by 4
“Obstetric and perinatal complications are particularly common in GDM subtypes with early onset and need for pharmacological treatment [4, 5].”
BackgroundKatayama, A., Hasegawa, M., Morimoto, E., Watanabe, M., Matsushita, Y., Takeda, M., Kai, K., Yoshida, M., 塚原, 紗., Okimoto, N., et al. (2025) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2025-005114 · Cited by 3
Nekkanti, M., Duraiswamy, M., Kamalanathan, S., Mohan, V., Venkatesh, Y. S., & Sagili, H. (2025) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_133_25 · Cited by 3
“[5,13,14,17,22] A systematic review and metanalysis of 13 cohort studies revealed that perinatal mortality (relative risk [RR]: 3.58 [1.91, 6.71]), neonatal hypoglycaemia (RR: 1.61 [1.02, 2.55]), and insulin use (RR: 1.71 [1.45, 2.03]) were greater among EGDM women compared to LGDM women, despite…”
InfluentialYe, Y., Qin, K.-Z., Xiong, Y., Wu, J., Zhou, Q., Xiao, X., & Li, X. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.743170 · Cited by 4
Maternofetal outcomes in early-onset gestational diabetes: does weight gain matter?
Monteiro, S. S., Santos, T., Fonseca, L., Saraiva, M., Pereira, T. A. R., Vilaverde, J., Pichel, F., Pinto, C., Almeida, M. C., & Dores, J. M. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01855-x · Cited by 3
Chigusa, Y., Ikeda, Y., Yamamura, A., Mogami, H., Nishimura, A., Morita, S., Mandai, M., & Harashima, S. (2025) · Obstetrics & Gynecology Science · doi:10.5468/ogs.25052 · Cited by 4
“Compared with GDM diagnosed after 24 weeks of gestation, early GDM is associated with a higher risk of pregnancy complications, including hypertensive disorders of pregnancy and cesarean delivery, and often necessitates insulin therapy [7,8].”
Predictive Power of Unconjugated Estriol in Diagnosis of Gestational Diabetes: A Cohort Study
Amirian, A., Kariman, N., Hedayati, M., Borumandnia, N., & Sheikhan, Z. (2019) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.96471 · Cited by 2
Pregestasyonel Diyabet ve Fetal Programlama
Aslan, B., & Caferoğlu, Z. (2020) · Journal of Nutrition and Dietetics · doi:10.33076/2020.bdd.1364 · Cited by 2
Dy, K., & Yao, C. (2022) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.037.02.05 · Cited by 1
Kasuga, Y., Kajikawa, K., Ishikawa, N., OGATA, Y., Takahashi, M., Akita, K., Tamai, J., Fukuma, Y., Tanaka, Y., Otani, T., et al. (2025) · Nutrients · doi:10.3390/nu17030440 · Cited by 1
Iqbal, R. A., & Nazir, S. (2025) · Reproductive Biology · doi:10.1016/j.repbio.2025.101059 · Cited by 3
A bibliometric and visual analysis of global gestational diabetes mellitus over the past 24 years
Sun, Y., Zhu, L.-M., Wei, C.-X., & Ren, Y.-J. (2025) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-025-01752-z · Cited by 2
D’Souza, A., Abdullahi, H., & Ibrahim, I. I. (2026) · International Journal of Endocrinology · doi:10.1155/ije/3725182 · Cited by 2
“These fndings also contrast with the literature, which suggests increased complications and a greater need for insulin and/or metformin treatment compared with standard practice, despite early screening and treatment of GDM [27, 29, 32, 33].”
Dib, S., Luo, N., Jones, D. L., Smith, S. J., Taylor, R., Murphy, H. R., Kusinski, L. C., & Meek, C. L. (2026) · Endocrine · doi:10.1007/s12020-025-04542-y · Cited by 1
“This is in line with prior studies demonstrating risk of dysglycemia in the post-partum period following an early GDM diagnosis [4, 16, 17], including higher risk of type 2 diabetes within 3 years [17 ].”
Mei, G., Xia, Y., Gan, J., & Chen, B. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70982 · Cited by 1
Fazel-Sarjuei, Z., Amirali, K. N., Kamali, M., Nazanin, K. N., & Ali, T. (2016) · Cited by 1
Le diabète gestationnel dépisté précocement : beaucoup d’incertitudes
Vambergue, A. (2017) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(17)30118-9 · Cited by 3
Shahid, M. M., Ronald, G. R., Thouhidur, R. K., Kamrul-Hasan, A. B. M., & Mohammad, F. S. (2020) · International Journal of Clinical Endocrinology and Metabolism · doi:10.17352/ijcem.000049 · Cited by 1
Heyborne, K., & Barbour, L. A. (2022) · JAMA · doi:10.1001/jama.2022.9409 · Cited by 1
Outcome of Gestational Diabetes during Pregnancy and at Delivery
Shaikh, H. A., Khan, S., Mustafa, A., Depar, A. A., Mateen, B., & Shaikh, M. T. A. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs22169811 · Cited by 1
McGrath, N., Chepulis, L. M., Nguyen, H., Yu, A., & Ashford, T. (2023) · New Zealand Medical Journal · doi:10.26635/6965.6082 · Cited by 1
Kasuga, Y., Miyakoshi, K., Yokoyama, M., Nakanishi, S., Iwama, N., Ichikawa, R., Abiko, A., Harashima, S., & Sugiyama, T. (2024) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15929 · Cited by 1
Metadata
- Authors
- Sweeting, A. N., Ross, G. P., Hyett, J., Molyneaux, L., Constantino, M., Harding, A. J., & Wong, J.
- Affiliations
- The University of Sydney (AU)
- Royal Prince Alfred Hospital (AU)
- Corresponding author
- Sweeting, Arianne N.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2015-12-05
- Volume
- 39
- Issue
- 1
- Pages
- 75-81
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2209588964
- Semantic Scholar
- c01f8c75daf8185a9473a20188d2f730be4af574
- Cited by
- 263
- References
- 36
- Citations by year
- 2026: 12 · 2025: 24 · 2024: 32 · 2023: 30 · 2022: 33 · 2021: 30 · 2020: 40 · 2019: 22 · 2018: 21 · 2017: 10 · 2016: 8
- FWCI
- 14.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Keywords
- gestational diabetes mellitus, early pregnancy diagnosis, pregestational diabetes, high-risk pregnancy, glycemic control, hypertensive disorders of pregnancy, preeclampsia, preterm birth, cesarean section, neonatal jaundice, macrosomia, large for gestational age, neonatal intensive care admission, pregnancy outcomes
- MeSH terms
- Adult, Birth Weight, Blood Glucose, Cesarean Section, Female, Fetal Macrosomia, Humans, Infant, Newborn, Jaundice, Neonatal, Pre-Eclampsia, Pregnancy, Pregnancy Complications, Pregnancy Outcome, Cohort Studies, Diabetes, Gestational, Premature Birth
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.